NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.83
0.00 (0.00%)
At close: Aug 15, 2025, 2:20 PM

NeuroOne Medical Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
5.76M 5.75M 3.45M 3.92M 3.73M 2.82M 1.95M 1.28M 681.59K 252K 171.17K 150.72K 158.76K 140.42K 178.15K 2.06M 2.02M 2M
Cost of Revenue
2.64M 3.01M 2.37M 2.79M 2.63M 2.08M 1.5M 1.03M 683.87K 322K 241.96K 223.58K 247.05K 213.61K 275.89K 782.8K 1.17M 1.47M
Gross Profit
3.12M 2.74M 1.08M 1.13M 1.09M 735.14K 456.52K 247.8K -2.28K -70K -70.79K -72.86K -88.29K -73.19K -97.75K 1.27M 848.26K 527.28K
Operating Income
-6.58M -6.79M -11.89M -12.24M -12.95M -13.56M -11.96M -10.19M -9.44M -9.01M -10.03M -11.27M -11.55M -10.88M -10.22M -7.69M -6.25M -5.23M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.6M -7.19M -12.32M -12.1M -12.8M -13.47M -11.86M -10.1M -9.39M -8.92M -10M -11.27M -11.46M -10.8M -9.95M -7.87M -12.01M -10.96M
Net Income
-6.6M -7.19M -12.32M -12.1M -12.8M -13.47M -11.86M -10.1M -9.39M -8.92M -10M -11.27M -11.46M -10.8M -9.95M -7.87M -12.01M -10.96M
Selling & General & Admin
7.71M 7.77M 7.9M 7.64M 7.62M 7.44M 6.93M 7.24M 6.9M 6.9M 6.98M 6.71M 7.31M 6.81M 6.26M 5.9M 4.91M 4.63M
Research & Development
4.99M 4.75M 5.07M 5.73M 6.43M 6.86M 6.94M 6.6M 5.93M 5.43M 4.93M 4.5M 4.18M 4.05M 3.93M 3.7M 3.25M 2.51M
Other Expenses
-3M -2.97M 31.01K 60.63K 60.63K 29.62K 81.21K 77.44K 79.14K 80.89K 31.15K 6.26K 4.55K 4.58K 187.74K 186.78K 186.78K 185K
Operating Expenses
9.7M 9.53M 12.97M 13.37M 14.05M 14.3M 12.41M 10.44M 9.44M 8.94M 9.96M 11.2M 11.46M 10.81M 10.12M 9.54M 8.12M 7.12M
Interest Expense
324.74K 324.74K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.05K 80.86K 4.83M 4.83M
Selling & Marketing Expenses
-65.05K -49.27K n/a 127.35K 131.84K 169.68K 173.43K 208.73K 202.72K 262.3K 270.61K 335.44K 371.22K 371.17K 309.83K 192.4K 113.14K n/a
Cost & Expenses
12.34M 12.54M 15.34M 16.16M 16.68M 16.38M 13.91M 11.47M 10.12M 9.26M 10.2M 11.43M 11.71M 11.02M 10.4M 9.75M 8.27M 7.23M
Income Tax Expense
n/a n/a 3.00 18.7K 18.7K 18.7K 13K -5.7K -32.81K -59.48K -80.02K -79.06K -51.95K -23.5K 2.73K 1.77K 1.77K n/a
Shares Outstanding (Basic)
31.11M 30.84M 26.76M 27.35M 25.91M 24M 23.52M 17.58M 16.41M 16.23M 16.22M 16.19M 16.19M 15.41M 12.01M 11.96M 11.24M 7.68M
Shares Outstanding (Diluted)
31.11M 30.88M 26.76M 27.35M 25.91M 24M 23.52M 17.58M 16.41M 16.23M 16.22M 16.19M 16.19M 15.41M 12.01M 11.96M 11.24M 7.68M
EPS (Basic)
0.23 0.19 -0.01 -0.48 -0.58 -0.68 -0.65 -0.6 -0.57 -0.55 -0.62 -0.76 -0.84 -0.86 -0.94 -0.8 -1.88 -1.96
EPS (Diluted)
0.23 0.19 -0.01 -0.48 -0.58 -0.68 -0.65 -0.6 -0.57 -0.55 -0.62 -0.76 -0.84 -0.86 -0.94 -0.8 -1.88 -1.96
EBITDA
-5.72M -6.34M -11.84M -11.99M -12.71M -13.34M -11.76M -9.99M -9.27M -8.85M -9.89M -11.13M -11.32M -10.67M -9.81M -7.68M -7.09M -6.05M
EBIT
-5.97M -6.59M -12.09M -12.24M -12.95M -13.56M -11.96M -10.16M -9.42M -8.98M -10M -11.27M -11.46M -10.8M -9.95M -7.79M -7.18M -6.13M
Depreciation & Amortization
11.2K 6.47K n/a 245.17K 239.02K 222.03K 199.26K 197.75K 199.41K 210.71K 226.21K 224.06K 194.47K 165.94K 133.28K 88.2K 72.05K 56.45K